Acid suppression in the elderly

Australasian Journal on Ageing

Volumn 25, Issue 3, 2006, Pages 164-166

  Manoharan, Thenmozhi ^a   Darzins, Peteris ^b  

^a Kingston Centre   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

80 and older; Aged; Anti ulcer agents

Indexed keywords

EID: 77956892207     PISSN: 14406381     EISSN: 17416612     Source Type: Journal    
DOI: 10.1111/j.1741-6612.2006.00174.x     Document Type: Article

References (12)

1. Pharmaceutical Benefits Branch. Expenditure and prescriptions twelve months to 30 June 2005. Accessed 26 June 2006. Available from URL: http://www.health.gov.au/internet/wcms/publishing.nsf/Content/1CF96D8028AE509ECA2570BA001AC076/$File/complete.pdf.
2. Klasco RK, ed. DRUGDEX® System. Greenwood Village, CO: Thomson MICROMEDEX (Edition expires 12/2004).
3. Klasco RK, ed. DISEASEDEX™ - Emergency Medicine. Greenwood Village, CO: Thomson MICROMEDEX (Edition expires 12/2004).
4. Laheij R, Sturkenboom M, Hassing RJ et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. Journal of the American Medical Association 2004; 292: 1955-1960.
5. Di Mario F, Battaglia G, Leandro G et al. Short-term treatment of gastric ulcer, a meta-analytical evaluation of blind trials. Digestive Diseases and Sciences 1996; 41: 1108-1131.
6. Salas M, Ward A, Caro J. Are proton pump inhibitors the first choice for acute treatment of gastric ulcers? A meta analysis of randomised clinical trials. BMC Gastroenterology 2002; 2: 17.
7. Palmer RH, Frank WO, Karlstadt RK. Maintenance therapy of duodenal ulcer with H2-receptor antagonists - a meta-analysis. Alimentary Pharmacology and Therapeutics 1990; 4: 283-294.
8. Therapeutic Guidelines Ltd. Therapeutic Guidelines: Gastrointestinal. Version 3. North Melbourne: Therapeutic Guidelines Ltd, 2002.
9. Caro J, Salas M, Ward A. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomised clinical trials. Clinical Therapeutics 2001; 23: 998-1017.
10. van Pinxteren B, Numans ME, Bonis PA, Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. The Cochrane Library 2004; 2.
11. Rostom A, Dube C, Wells G et al. Prevention of NSAID-induced gastro-duodenal ulcers. The Cochrane Library 2004; 2.
12. Moayyedi P, Soo S, Deeks J et al. Pharmacological interventions for non-ulcer dyspepsia. The Cochrane Library 2004; 2.